Hempvana Cold as Ice

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults, the recommended application is to the affected area not more than 3 to 4 times daily. In the event that the product comes into contact with the hands, it is advised to wash the hands thoroughly with soap and water.

For children under 18 years of age, it is essential to consult a physician prior to use.

Contraindications

The product should not be used in large quantities, particularly over raw surfaces or blistered areas, as this may exacerbate irritation or lead to adverse effects. Application to wounds or damaged skin is contraindicated due to the potential for increased absorption and systemic effects. Additionally, tight bandaging is not recommended, as it may restrict circulation and lead to complications.

Warnings and Precautions

This product is intended for external use only. It is important to note that the formulation is flammable; therefore, it should be kept away from excessive heat and open flames to prevent any fire hazards.

When utilizing this product, it is crucial to avoid contact with the eyes. In the event of accidental contact, immediate rinsing with water is recommended.

Healthcare professionals should advise patients to discontinue use and consult a physician if the condition worsens, if symptoms persist for more than seven days, or if symptoms resolve and then recur within a few days. These actions are essential to ensure appropriate medical evaluation and intervention.

Additionally, this product must be kept out of reach of children. In cases where the product is ingested, it is imperative to seek emergency medical assistance or contact a Poison Control Center without delay. This precaution is vital to ensure the safety and well-being of patients, particularly children.

Side Effects

Patients should be aware of the following warnings associated with the use of this product. It is intended for external use only and is flammable; therefore, it should be kept away from excessive heat or open flame.

In the event that the condition worsens, or if symptoms persist for more than 7 days or clear up and then occur again within a few days, patients are advised to stop use and consult a doctor.

Additionally, it is crucial to keep this product out of reach of children. If the product is swallowed, immediate medical assistance should be sought, or contact with a Poison Control Center should be made right away.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Hempvana Cold as Ice (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 18 years of age should be evaluated by a physician prior to use. It is essential to consider the specific needs and conditions of this population to ensure appropriate care and treatment.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of Hempvana Cold As Ice Pain Relief (menthol gel) during pregnancy. As such, the safety of this product in pregnant patients has not been established. Healthcare professionals should exercise caution when recommending this product to women of childbearing potential. Due to the lack of data on potential fetal impacts, it is advisable to consider alternative pain relief options that have established safety profiles during pregnancy. Further research may be necessary to clarify the implications of using this product in pregnant individuals.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the product is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific product and the amount ingested; therefore, a thorough assessment by a medical professional is recommended.

Management of overdosage should be guided by the clinical presentation and may involve supportive care and symptomatic treatment as necessary. It is imperative that healthcare providers remain vigilant and prepared to implement appropriate interventions based on the patient's condition.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion. In the event that the product is swallowed, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be instructed not to use the product in large quantities, especially over raw surfaces or blistered areas, and to avoid applying it to wounds or damaged skin. It is important to inform patients that they should not bandage the area tightly after application.

Healthcare providers should counsel patients to stop using the product and consult a doctor if their condition worsens. Additionally, patients should be advised to seek medical advice if symptoms persist for more than 7 days or if symptoms clear up and then recur within a few days.

Finally, patients should be reminded to avoid contact with their eyes while using this product to prevent irritation or injury.

Storage and Handling

The product is supplied in a tightly closed container to ensure its integrity. It should be stored in a cool, dry place to maintain its efficacy and stability. Proper storage conditions are essential to prevent degradation and ensure optimal performance.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of no more than 3 to 4 times daily for adults to the affected area. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Hempvana Cold as Ice, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)